Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W

AIMS: To assess the risk of death after the occurrence of different types of non-fatal events in patients with atrial fibrillation (AF). Antithrombotic therapies in AF have primarily focused on stroke prevention and bleeding. However, strokes and bleeds differ in severity, and the level of severity may differently impact mortality. METHODS AND RESULTS: We analysed the risk of subsequent mortality after the occurrence of non-fatal vascular and …